TeleCIMT: Tele-rehabilitation Through CIMT at Recovering the Function of the Upper Limb and Quality of Life

Sponsor
Universidad de La Frontera (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04877418
Collaborator
(none)
70
1
1
2
35.5

Study Details

Study Description

Brief Summary

The current pandemic scenario is immensely challenging for healthcare professionals. Telerehabilitation,is a promising option that benefited many people, allowing continuity of therapeutic processes and promoting the admission of people without prior access to rehabilitation programs. This modality has shown comparable results with conventional rehabilitation strategies, applied in patients with neurological pathologies. However, the modalities applied and the quality of the studies are insufficient to establish their real benefits and effectiveness.

Strategies such as CIMT, have been shown to be effective in improving upper limb function and restoring quality of life in stroke survivors. However, there is little evidence on its effectiveness when administered under telerehabilitation modality.

Condition or Disease Intervention/Treatment Phase
  • Procedure: TeleCIMT
N/A

Detailed Description

Objective To determine if movement-induced restriction therapy, delivered through telerehabilitation (TeleCIMT), recovers function and improves quality of life in patients with brachial sequelae, after a stroke.

Methodology A prospective, single-group experimental study will be conducted. The sample will be of an intentional type, selected according to meeting the inclusion criteria. Each participant will be evaluated three times, at the beginning, middle and end of the intervention using TeleCIMT. The evaluation scales to be used will be Motor Activity Log-30 (MAL-30) and Action Research Arm for function and ECVI-38 scale for quality of life. The difference between these measurements in each patient (change score) will express the progress (or setback) obtained through this modality of intervention via telerehabilitation. Specifically, the effects of the TeleCIMT will be examined by one-factor within-subject analysis of variance (ANOVA) using time (T1, T2, and T3) as the independent variable and the recovery measures as dependent variables. In all analyzes, results with p values less than or equal to 0.05 will be considered statistically significant.

Expected results Through this proposal, the aim is to promote a line of research that allows the development of scientific evidence in the area of telerehabilitation in subjects with neurological pathologies. This information will benefit numerous professionals, promoting timely access to rehabilitation, providing continuity in therapeutic processes and reversing levels of disability due to neurological pathologies.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Tele-rehabilitation Through Constraint Induced Movement Therapy (TeleCIMT) at Recovering the Function of the Upper Limb and Quality of Life
Anticipated Study Start Date :
May 1, 2022
Actual Primary Completion Date :
May 20, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: TeleCIMT group

One month after baseline evaluations, patients will receive a 3-week program through TeleCIMT. Task Oriented Repetitive Training Use of the Affected Upper Extremity Transfer Package

Procedure: TeleCIMT
Mode applied remotely, through the principles and components of the CIMT protocol.

Outcome Measures

Primary Outcome Measures

  1. Upper limb function in patients after stroke. [3 weeks]

    MAL: It is a structured interview, composed by 30 items, intended to examine how much and how well the subject uses their more-affected arm outside of the laboratory setting. During the test administration. participants should be told that they can give half scores (i.e., 0.5,1.5,2.5,3.5,4.5) if this is reflective of their ratings. ARAT: It is a performance test that evaluates the ability of the affected upper limb to pick up, move and grasp objects of different size, weight and shape in patients with cortical injury. It is composed of 19 items that examine grip, grip, clamp and gross movement. The total score ranges from 0 (none of the movements were performed) to 57 (all the movements were performed without difficulty). The application of both instruments will be carried out virtually according to standardized procedures.

Secondary Outcome Measures

  1. The quality of life of patients after stroke. [3 weeks.]

    It will be evaluated through the ECVI-38 scale, which comprises 38 items grouped into 8 subscales: physical state, communication, cognition, emotions, feelings, basic activities of daily life, common activities of daily life and socio-family functioning. It also contains two additional questions about sexual relationships and work activity. The application will be carried out virtually according to standardized procedures in the manual. The formulation of responses is with a Likert scale, from 5 to 1, where 5 is the worst score as evaluated and 1 is where the patient reports having no difficulty.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged between 30 and 80 years.

  • Who present a single stroke event confirmed by CT,

  • Between 5 and 14 points on the NIHSS Scale

  • Who have the ability to sit independently.

  • Who can follow simple instructions (score greater than 13 on the Mini Menta)l.

  • <2 points on the Modified Ashworth Scale on elbow and wrist

  • <4 points on the Visual Analog Scale on shoulder.

  • That they can perform a functional test of 20 ° of wrist extension and 10 ° of finger extension (take and drop a cloth with the affected hand).

Exclusion Criteria:
  • Severe cognitive impairment (aphasia, attention deficit, reasoning or memory disorders).

  • Severe sensory impairment (visual-auditory).

  • Orthopedic limitation (use of a cane).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universidad de La Frontera Temuco Chile

Sponsors and Collaborators

  • Universidad de La Frontera

Investigators

  • Principal Investigator: Arlette Doussoulin, PHD, Universidad de La Frontera

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ARLETTE PATRICIA DOUSSOULIN SANHUEZA, Principal Investigator, Universidad de La Frontera
ClinicalTrials.gov Identifier:
NCT04877418
Other Study ID Numbers:
  • DIUFRO
First Posted:
May 7, 2021
Last Update Posted:
May 24, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by ARLETTE PATRICIA DOUSSOULIN SANHUEZA, Principal Investigator, Universidad de La Frontera

Study Results

No Results Posted as of May 24, 2022